MDCX
Medicus Pharma Ltd. Common Stock
Mentions (24Hr)
500.00% Today
Reddit Posts
Mentions
Thoughts on MDCX ? Is there anyway this thing rockets tomorrow ?
Thought we were supposed to hear news about MDCX after market - I know tomorrow morning may be news as well -
Okay MDCX your turn tomorrow 🙏
So are we expecting to hear anything about MDCX after market close ?
Officially in MDCX - $0.4847 Terrible chart- but lots of possible climbs to come if news tonight and tomorrow are decent or hopefully great
MDCX chart looks . . . interesting. What's with this one?
$MDCX multi bagger play tonight into tomorrow—don’t hold back
ANYLOVE - what’s your thoughts on MDCX?
$MDCX!!! 10-K coming tonight and webcast tomorrow, after positive phase 2 results the CEO has expressed their interest in partnerships, and many different things that have the potential to 4x this micro cap. Also on track for an end-of-phase 2 meeting with the FDA H1 2026.
MDCX? Tomorrow ? What are our thoughts ?
MDCX but before announcement
MDCX readout Friday!!! Partnerships coming!!! This is severely beaten down with a 27$ PT updated last week, that’s 54x current price…
$MDCX has strong overnight volume, catalyst this week, and has been deeply undervalued due to an overreaction to a (mostly positive) readout
MDCX. I hit the jackpot!!!!!
No mention of MDCX have a look
Curious on your thoughts on MDCX at these levels
ASPI and MDCX. your welcome
buy ASPI and MDCX and HOOD on the dips
Get in [to MDCX], losers. We're going
Saw a CNBC commercial for MDCX so I'm full port they clearly solved health care
stay poor if you don´t use the paid version of gemini, that fucker went through the whole FDA list of new drugs with most potential customers and phase 3 trials q2 2025 for me and found $MDCX for me BOOM +70% chatgpt and claude will only make you poorer.
**Thursday, 6****^(th)** **March at 7:30 am** PHILADELPHIA, March 06, 2025 (GLOBE NEWSWIRE) -- Medicus Pharma Ltd. (NASDAQ: MDCX) ("Medicus" or the "Company") is pleased to announce a positively trending interim analysis for SKNJCT-003 Phase 2 clinical study to non-invasively treat basal cell carcinoma of the skin (BCC).